Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper

Nicolò Matteo Luca Battisti, Alistair Ring, Gábor Liposits et al.|Therapeutic Advances in Medical Oncology|2018

Cited by 61